Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|September 16, 2021
Hepatocellular Carcinoma in Non-cirrhotic Liver Arises with a More Advanced Tumoral Appearance: A Single-Center Cohort StudyCoşkun Özer Demirtaş, Tuğba Tolu, Çaglayan Keklikkıran, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|November 10, 2020
Effect of carbon dioxide versus room air insufflation on post-colonoscopic pain: A prospective, randomized, controlled studyFeyza Gündüz, Haluk Tarık Kani, Shannon Chang, et al.
Digestive Diseases and Sciences|May 2, 2013
Relationship between neutrophil gelatinase-associated lipocalin (NGAL) levels and inflammatory bowel disease type and activityAtakan Yeşil, Can Gönen, Ebubekir Senateş, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|May 7, 2021
Recommendations for Reopening Endoscopy Units in Turkey: A Set-up Plan from a Tertiary Center in IstanbulCoşkun Özer Demirtas, Çağlayan Keklikkıran, Shahin Mehdiyev, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|September 19, 2019
Evaluation of depression, anxiety and quality of life in hepatitis C patients who treated with direct acting antiviral agentsOğuzhan Kesen, Haluk Tarık Kani, Ömer Yanartaş, et al.
Journal of Gastrointestinal Cancer|March 23, 2010
The prevalence of the mutation in codon 249 of the P53 gene in patients with hepatocellular carcinoma (HCC) in TurkeyFiliz Türe Ozdemir, Arzu Tiftikci, Seda Sancak, et al.
Clinical and Experimental Rheumatology|January 26, 2012
PDCD1 polymorphisms are not associated with Takayasu's arteritis in TurkeyHaner Direskeneli, Ezgi Tuna-Erdoğan, Feyza Gündüz, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|February 24, 2021
Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experienceBülent Değertekin, Mehmet Demir, Ulus S Akarca, et al.
Pageof 1